Josh Friedman
- Indexed articles, last 90 days
- 45
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Smoking demonstrates âprofoundâ association with sarcoma progression, distant metastases (opens the original)
Read excerpt
Smoking may significantly increase risk for progression and metastases for patients with sarcoma. The findings, presented at the American Society for Radiation Oncology Annual Meeting, showed active smokers had worse outcomes at both 2 years and 5 years, including nearly a twofold greater risk for distant metastases. âThe difference is profound,â Meena Bedi, MD, MS, division chair of radiation oncology for Cleveland Clinic Florida, told Healio. Researchers estimate more than 18,000 individua
SBRT improves multiple quality of life outcomes vs. surgery in localized prostate cancer (opens the original)
Read excerpt
Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and sexual function, for men with low- or intermediate-risk prostate cancer compared with prostatectomy. Data from the phase 3 randomized PACE-A trial, presented at the American Society for Radiation Oncology Annual Meeting, showed use of urinary pads to be 40% lower in patients who received five-fraction stereotactic body radiation therapy (SBRT), with no differences in biochemica
Multi-fraction radiation significantly improves local control for large brain metastases (opens the original)
Read excerpt
Stereotactic radiation delivered over three to five sessions after surgery significantly improved local control for patients with large, resected brain metastases compared with single fraction treatment. Results from the first randomized phase 3 trial comparing differing radiation schedules, presented at American Society for Radiation Oncology Annual Meeting, also showed an association with a 9-month survival benefit for patients who received treatment over multiple visits. âThis was a positiv
âEye-openingâ: AI could be low-cost solution to clinical trial consent form translation (opens the original)
Read excerpt
It can cost more than $10,000 to translate an informed consent form for a clinical trial into another language, according to the author of a study published in JCO Oncology Practice. Many investigator-initiated trials do not have the budget for that, Carmen E. Guerra, MD, MSCE, FACP, Ruth C. and Raymond G. Perelman Professor of Medicine at Penn Medicine, told Healio. This then prohibits enrollment of patients with limited English proficiency (LEP) â or approximately 8% of the U.S. population.
Not âirrelevantâ: Thymus health may have significant impact on mortality, cancer outcomes (opens the original)
Read excerpt
When Hugo Aerts, PhD, started asking colleagues whether the thymus could play a role in determining which patients with cancer would respond to immunotherapy about 4 years ago, the responses were overwhelmingly dismissive. âItâs irrelevant,â they told him. â[The thymus is] important in kids. Afterwards, it doesnât matter.â âAre you sure?â Aerts, director of the Artificial Intelligence in Medicine Program at Mass General Brigham, asked. âWe have the data. Letâs investigate thi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.